ZMIZ1
protein-codingzinc finger MIZ-type containing 1, the group of Zinc fingers MIZ-type
Gene summary
This gene encodes a member of the PIAS (protein inhibitor of activated STAT) family of proteins. The encoded protein regulates the activity of various transcription factors, including the androgen receptor, Smad3/4, and p53. The encoded protein may also play a role in sumoylation. A translocation between this locus on chromosome 10 and the protein tyrosine kinase ABL1 locus on chromosome 9 has been associated with acute lymphoblastic leukemia. [provided by RefSeq, Mar 2010]
- RAI17
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~247.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0032855
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0032855
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0032855
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0000508
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0032855
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0100038
Submitter: ClinGen
ZMIZ1 (HGNC: 16493) located on 10q22, encodes a member of the PIAS (protein inhibitor of activated STAT) family of proteins. The protein acts as transcriptional coactivator in the TGF-beta signaling pathway by increasing the activity of the SMAD3/SMAD4 transcriptional complex (PMID:16777850). It is also involved in the transcriptional activation of a subset of NOTCH1 target genes including MYC, thymocyte and T cell development and in the regulation of postmitotic positioning of pyramidal neurons in the developing cerebral cortex (PMID:30639322). ZMIZ1 variants have been detected in a dozen of unrelated patients from different groups and in both sexes with common clinical features of neurodevelopmental disorder with dysmorphic facies and distal skeletal anomalies (OMIM #607159). Associated features include growth failure, feeding difficulties, microcephaly, facial dysmorphism, various other congenital malformations (PMID: 30639322; 31833199, 34680978). ZMIZ1 variants carriers show diverse phenotypes and being affected in multiple organs, thus ZMIZ1 is lumped to Complex neurodevelopmental disorder (MONDO:0100038). Identified ZMIZ1 variants show mostly de novo (PMID: 30639322; 35432459). In some cases, however, ZMIZ1 are found to be inherited from the parents (PMID: 34680978; 31833199). ZMIZ1 mutant alleles in developing mouse brains using in utero electroporation resulted in abnormal pyramidal neuron morphology, polarization, and positioning (PMID: 30639322). Based on the consistent phenotypes; sufficient genetic and experimental evidence, ZMIZ1 is curated as “Definitive” for Complex neurodevelopmental disorder.
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Musculoskeletal; Neurologic; Ophthalmologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ZMIZ1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_020338.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 8 | 175 | 17 | 201 | |
| missense | 3 | 5 | 336 | 63 | 19 | 426 |
| nonsense | 6 | 5 | 11 | |||
| start loss | 0 | |||||
| frameshift | 10 | 19 | 4 | 33 | ||
| splice donor/acceptor (+/-2bp) | 9 | 7 | 16 | |||
| Total | 19 | 39 | 355 | 238 | 36 | 687 |
Highest pathogenic variant AF is 0.000004125634
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_065071.1 | 21 | MANE Select | |
| Ensembl | ENSP00000334474.5 | 21 | MANE Select | |
| Ensembl | ENSP00000550259.1 | 20 | Standard | |
| Ensembl | ENSP00000550259.1 | 20 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Androgen receptor signaling pathway
- AndrogenReceptor
- Coregulation of Androgen receptor activity
Biological Process
- vasculogenesis
- in utero embryonic development
- heart morphogenesis
- vitellogenesis
- cell aging
Molecular Function
- zinc ion binding
Cellular Component
- nucleoplasm
- cytoplasm
- nuclear speck
- intracellular membrane-bounded organelle
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000334512
- Coding exons
- 21
- Length
- 247485
- Individuals with no LoFs
- 125733
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 13
- Defined
- 125746
- p
- 0.0000517
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 3.39 | 447 | 699 | 0.639 | 0.0000444 | 7017 |
| Missense (PolyPhen) | 129 | 265.38 | 0.4861 | 2544 | ||
| Synonymous | -0.684 | 318 | 303 | 1.05 | 0.0000224 | 2138 |
| Loss of Function | 5.79 | 7 | 52.1 | 0.134 | 0.00000265 | 521 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000062 | 0.000062 | rare |
| Latino/Admixed American | 0.00017 | 0.00017 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000054 | 0.000054 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000018 | 0.000018 | rare |
| South Asian | 0.000098 | 0.000098 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Acts as transcriptional coactivator. Increases ligand- dependent transcriptional activity of AR and promotes AR sumoylation. The stimulation of AR activity is dependent upon sumoylation (PubMed:14609956, PubMed:26522984). Involved in transcriptional activation of a subset of NOTCH1 target genes including MYC. Involved in thymocyte and T cell development (By similarity). {ECO:0000250|UniProtKB:Q6P1E1, ECO:0000269|PubMed:14609956, ECO:0000269|PubMed:26522984}.;
Recessive Scores
- pRec
- 0.123
Intolerance Scores
- LoFtool
- 0.154
- RVIS EVS
- -2.04
- RVIS percentile EVS
- 1.66
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- S
- Essential (gene trap)
- K
- Indispensability pred.
- E
- Indispensability score
- 0.956
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |